azd0291
AstraZeneca lung cancer data reveals promise
May 15, 2014Sales and Marketing ASCO, AstraZeneca, NSCLC, azd0291, lung cancer
AstraZeneca has released promising data in a lung cancer trial with one of its investigational drugs, AZD9291, which has breakthrough …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
The evidence bar impacting UK medical cannabis access
November 6, 2026
